Analytical characterization of "etonitazepyne," a new pyrrolidinyl-containing 2-benzylbenzimidazole opioid sold online.

Drug Test Anal

Laboratory for Medicines and Health Care Products, Scientific Direction of Physical and Chemical Health Risks, Sciensano, Brussels, Belgium.

Published: September 2021

This paper reports on the identification and full chemical characterization of the substance colloquially called "etonitazepyne" or "N-pyrrolidino etonitazene" (2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzo[d]imidazole), a potent NPS opioid of the 5-nitrobenzimidazole class. Identification of etonitazepyne was performed, on a sample purchased during routine monitoring of the drug market, using GC-MS, HRAM LC-MS/MS, H NMR, and FTIR. The chromatographic data, together with the FTIR data, indicated the presence of a highly pure compound and already indicated a benzimidazole structure. The specific benzimidazole regio-isomer was confirmed using H NMR spectroscopy, resulting in the unambiguous identification of etonitazepyne.

Download full-text PDF

Source
http://dx.doi.org/10.1002/dta.3113DOI Listing

Publication Analysis

Top Keywords

identification etonitazepyne
8
analytical characterization
4
characterization "etonitazepyne"
4
"etonitazepyne" pyrrolidinyl-containing
4
pyrrolidinyl-containing 2-benzylbenzimidazole
4
2-benzylbenzimidazole opioid
4
opioid sold
4
sold online
4
online paper
4
paper reports
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!